reaching large numbers of children with safe treatment for 
soil-transmitted helminthiases (STH) (round worm, whip 
worm, and hook worm) in particular. 
(b) UNITED NATIONS.—The President shall direct 
the United States permanent representative to the United 
Nations to use the voice, vote, and influence of the United 
States to urge the World Health Organization, the United 
Nations Educational, Scientific and Cultural Organiza-
tion, and the United Nations Development Programme to 
take the actions described in subsection (d). 
(c) WORLD BANK INSTITUTE.—The President shall 
direct the United States Executive Director at the Inter-
national Bank for Reconstruction and Development to use 
the voice, vote, and influence of the United States to urge 
the World Bank Institute to take the actions described 
in subsection (d). 
(d) ACTIONS DESCRIBED.—The actions described in 
this subsection are the following: 
(1) Ensure the dissemination of best practices 
and programming on NTDs to governments and 
make data accessible to practitioners in an open and 
timely fashion. 
(2) 
Highlight 
impacts 
of 
school-based 
deworming programs on children’s health and edu-
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00015
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
cation, emphasizing the cost-effectiveness of such 
programs. 
(3) Encourage governments to implement 
deworming campaigns at the national level. 
(4) Designate a portion of grant funds of the 
institutions to deworming initiatives and cross-sec-
toral collaboration with water and sanitation and hy-
giene efforts and nutrition or education program-
ming. 
(5) Encourage accurate monitoring and evalua-
tion of NTD programs, including deworming pro-
grams. 
(6) Engage governments in cross-border initia-
tives for the treatment, control, prevention, and 
elimination of NTDs, and assist in developing 
transnational agreements, when necessary. 
TITLE II—DEPARTMENT OF 
HEALTH AND HUMAN SERVICES 
SEC. 201. PROMOTING EFFORTS THROUGH INTERAGENCY 
WORKING GROUPS AND INTERNATIONAL FO-
RUMS. 
The Secretary of Health and Human Services shall 
continue to promote the need for robust programs and ac-
tivities to diagnose, prevent, control, and treat neglected 
tropical diseases— 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00016
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
(1) through interagency working groups on 
health; and 
(2) through relevant international forums on 
behalf of the United States, including the post-2015 
United Nations development agenda. 
SEC. 202. REPORT ON NEGLECTED TROPICAL DISEASES IN 
THE UNITED STATES. 
(a) IN GENERAL.—Not later than 12 months after 
the date of enactment of this Act, the Secretary of Health 
and Human Services, acting through the Director of the 
Centers for Disease Control and Prevention, shall submit 
to the Congress a report on neglected tropical diseases in 
the United States. 
(b) CONTENTS.—The report required by this section 
shall— 
(1) assess the epidemiology of, impact of, and 
appropriate funding required to address neglected 
tropical diseases in the United States; and 
(2) include the information necessary— 
(A) to guide future health policy with re-
spect to such diseases; 
(B) to accurately evaluate the current 
state of knowledge concerning such diseases; 
and 
(C) to define gaps in such knowledge. 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
SEC. 203. CENTERS OF EXCELLENCE. 
Part P of title III of the Public Health Service Act 
is amended by inserting after section 399V–5 of such Act 
(42 U.S.C. 280g–16) the following: 
‘‘SEC. 399V–6. NEGLECTED TROPICAL DISEASE CENTERS OF 
EXCELLENCE. 
‘‘(a) COOPERATIVE AGREEMENTS AND GRANTS.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the National Institute of Al-
lergy and Infectious Diseases or the Administrator 
of the Health Resources and Services Administra-
tion, as appropriate, may enter into cooperative 
agreements with, and make grants to, public or pri-
vate nonprofit entities to pay all or part of the cost 
of planning, establishing, or strengthening, and pro-
viding basic operating support for, one or more cen-
ters of excellence for research into, training in, and 
development of diagnosis, prevention, control, and 
treatment methods for neglected tropical diseases. 
‘‘(2) ELIGIBILITY.—To be eligible for a cooper-
ative agreement or grant under this section, an enti-
ty must— 
‘‘(A) have demonstrated expertise in re-
search on, and the epidemiology and surveil-
lance of, the major neglected tropical diseases 
that are endemic to the United States, such as 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
Chagas disease, dengue, leishmaniasis, and 
West Nile virus infection, and helminth infec-
tions; and 
‘‘(B) participate in one or more not-for- 
profit product development partnerships. 
‘‘(b) POLICIES.—A cooperative agreement or grant 
under paragraph (1) shall be entered into or awarded in 
accordance with policies established by the Director of the 
National Institutes of Health or the Health Resources and 
Services Administration, as applicable. 
‘‘(c) COORDINATION WITH OTHER INSTITUTES.— 
The Secretary shall coordinate the activities under this 
section with similar activities conducted by other national 
research institutes, centers, and agencies of the National 
Institutes of Health to the extent that such institutes, cen-
ters, and agencies have responsibilities that are related to 
neglected tropical diseases. 
‘‘(d) USES OF FUNDS.—A cooperative agreement or 
grant under subsection (a) may be used for— 
‘‘(1) staffing, administrative, and other basic 
operating costs, including such patient care costs as 
are required for research; 
‘‘(2) clinical training, including training for al-
lied health professionals, continuing education for 
health professionals and allied health professions 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
personnel, and information programs for the public 
with respect to neglected tropical diseases; and 
‘‘(3) research and development programs. 
‘‘(e) PERIOD OF SUPPORT; ADDITIONAL PERIODS.— 
‘‘(1) IN GENERAL.—Support of a center of ex-
cellence under this section may be for a period of 
not more than 5 years. 
‘‘(2) EXTENSIONS.—The period specified in 
paragraph (1) may be extended by the Secretary for 
additional periods of not more than 5 years if— 
‘‘(A) the operations of the center of excel-
lence involved have been reviewed by an appro-
priate technical and scientific peer review 
group; and 
‘‘(B) such group has recommended to the 
Secretary that such period should be extended. 
‘‘(f) DEFINITIONS.—In this section: 
‘‘(1) The term ‘neglected tropical disease’ has 
the meaning given to that term in section 5 of the 
End Neglected Tropical Diseases Act. 
‘‘(2) The term ‘product development partner-
ship’ means a partnership to bring together public 
and private sector researchers to develop new, or im-
prove on current, global health tools, such as drugs, 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
diagnostics, insecticides, vaccines, and vector man-
agement strategies— 
‘‘(A) that are for neglected tropical dis-
eases; and 
‘‘(B) for which there is generally no profit-
able market. 
‘‘(g) AUTHORIZATION
OF
APPROPRIATIONS.—To 
carry out this section, there are authorized to be appro-
priated such sums as may be necessary for each of the 
fiscal years 2015 through 2019.’’. 
SEC. 204. PANEL ON WORM INFECTION SOLUTIONS. 
(a) ESTABLISHMENT.—The Director of the National 
Institutes of Health, in consultation with the Adminis-
trator of the United States Agency for International De-
velopment, shall establish a panel to conduct an evaluation 
of issues relating to worm infections, including potential 
solutions such as deworming medicines (in this section re-
ferred to as the ‘‘panel’’). 
(b) STRATEGIES.—The panel shall develop rec-
ommendations for strategies for solutions with respect 
to— 
(1) repeat infections; 
(2) vector control; 
(3) clean water solutions; 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
(4) identifying incentives to encourage basic re-
search for less toxic, more effective medicines; and 
(5) improving the success and cost efficiency of 
current programs in these areas, based on a thor-
ough scan of initiatives already underway in both 
the public and private sectors. 
(c) APPOINTMENT OF MEMBERS.—The Director of 
the National Institutes of Health shall appoint as mem-
bers of the panel individuals from the public and private 
sectors who are knowledgeable about or affected by worm 
infections, including— 
(1) at least 2 representatives of nongovern-
mental organizations; 
(2) at least 2 representatives of private industry 
involved in the development of de-worming medica-
tions; 
(3) at least 2 representatives from academia; 
and 
(4) representatives of industries relating to 
sanitation, clean water, and vector control. 
(d) REPORT.—Not later than 1 year after the date 
of the enactment of this Act, the panel shall submit to 
Congress and the Director of the National Institutes of 
Health a report on its findings and recommended strate-
gies, including recommendations for such administrative 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS
action and legislation as the panel determines to be appro-
priate. 
(e) TERMINATION.—The panel shall terminate not 
later than 6 months after submitting the report required 
by subsection (d). 
Æ 
VerDate Mar 15 2010 
22:23 Jun 13, 2014
Jkt 039200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6301
E:\BILLS\H4847.IH
H4847
tkelley on DSK3SPTVN1PROD with BILLS